Back to search
Activated PI3K-delta Syndrome
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Activated PI3K-delta Syndrome trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Activated PI3K-delta Syndrome trials you may qualify forThis is a 2-part, prospective, open-label, single arm, multicenter study to evaluate the safety, tolerability, pharmacokinetics (PK), pharmacodynamics (PDx), an…
This study is designed to provide long-term CDZ173 treatment, a selective PI3Kδ inhibitor, to the patients with genetically activated PI3Kδ, i.e., patients with…
This is a 2-part, prospective, open-label, single arm, multicenter study to evaluate the safety, tolerability, pharmacokinetics (PK), pharmacodynamics (PDx), an…